CN116322701A - 新的改良释放的口服避孕组合物 - Google Patents

新的改良释放的口服避孕组合物 Download PDF

Info

Publication number
CN116322701A
CN116322701A CN202180070759.5A CN202180070759A CN116322701A CN 116322701 A CN116322701 A CN 116322701A CN 202180070759 A CN202180070759 A CN 202180070759A CN 116322701 A CN116322701 A CN 116322701A
Authority
CN
China
Prior art keywords
contraceptive
oral
dng
composition
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180070759.5A
Other languages
English (en)
Chinese (zh)
Inventor
恩利克·科利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiamo Experimental Co
Original Assignee
Jiamo Experimental Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiamo Experimental Co filed Critical Jiamo Experimental Co
Publication of CN116322701A publication Critical patent/CN116322701A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
CN202180070759.5A 2020-08-14 2021-08-13 新的改良释放的口服避孕组合物 Pending CN116322701A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20382753.0A EP3954364A1 (en) 2020-08-14 2020-08-14 New modified release oral contraceptive composition
EP20382753.0 2020-08-14
PCT/EP2021/072584 WO2022034209A1 (en) 2020-08-14 2021-08-13 New modified release oral contraceptive composition

Publications (1)

Publication Number Publication Date
CN116322701A true CN116322701A (zh) 2023-06-23

Family

ID=72145348

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180070759.5A Pending CN116322701A (zh) 2020-08-14 2021-08-13 新的改良释放的口服避孕组合物

Country Status (21)

Country Link
US (3) US12409141B2 (enExample)
EP (2) EP3954364A1 (enExample)
JP (1) JP2023538030A (enExample)
KR (1) KR20230067614A (enExample)
CN (1) CN116322701A (enExample)
AU (1) AU2021325372A1 (enExample)
BR (1) BR112023002654A2 (enExample)
CA (1) CA3191326A1 (enExample)
CL (1) CL2023000450A1 (enExample)
CO (1) CO2023002874A2 (enExample)
CR (1) CR20230127A (enExample)
DO (1) DOP2023000029A (enExample)
EC (1) ECSP23016038A (enExample)
IL (1) IL300578A (enExample)
JO (1) JOP20230032A1 (enExample)
MX (1) MX2023001868A (enExample)
PE (1) PE20231378A1 (enExample)
PY (1) PY2168235A (enExample)
UY (1) UY39379A (enExample)
WO (1) WO2022034209A1 (enExample)
ZA (1) ZA202303273B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260021110A1 (en) * 2024-07-18 2026-01-22 Chemo Research, S.L. Methods of oral contraception by controlled release of dienogest and ethynyl estradiol
WO2026146125A1 (en) 2024-12-30 2026-07-09 Chemo Research, S.L. Treatment of hirsutism, polycystic ovarian syndrome and other associated conditions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1835737A (zh) * 2003-06-13 2006-09-20 约翰·克劳斯·萨沃伊尔 由雌二醇和胆固醇组成的稳定形状颗粒的制备方法
CN101123952A (zh) * 2005-02-15 2008-02-13 拜耳先灵医药股份有限公司 固体口服避孕药
CN102119021A (zh) * 2008-08-08 2011-07-06 拜耳先灵医药股份有限公司 含有孕酮的药物递送系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340585A (en) 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
DK1848406T3 (da) * 2005-02-15 2008-09-15 Jenapharm Gmbh Fast, penoral lægemiddelform til kontraception, der indeholder dienogest og ethynylestradiol
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1835737A (zh) * 2003-06-13 2006-09-20 约翰·克劳斯·萨沃伊尔 由雌二醇和胆固醇组成的稳定形状颗粒的制备方法
CN101123952A (zh) * 2005-02-15 2008-02-13 拜耳先灵医药股份有限公司 固体口服避孕药
CN102119021A (zh) * 2008-08-08 2011-07-06 拜耳先灵医药股份有限公司 含有孕酮的药物递送系统

Also Published As

Publication number Publication date
UY39379A (es) 2022-01-31
CO2023002874A2 (es) 2023-04-05
CR20230127A (es) 2023-06-23
MX2023001868A (es) 2023-05-09
US12409141B2 (en) 2025-09-09
DOP2023000029A (es) 2023-07-09
IL300578A (en) 2023-04-01
PE20231378A1 (es) 2023-09-07
US20260027058A1 (en) 2026-01-29
AU2021325372A1 (en) 2023-03-30
EP3954364A1 (en) 2022-02-16
US12409142B2 (en) 2025-09-09
CL2023000450A1 (es) 2023-10-20
WO2022034209A1 (en) 2022-02-17
JOP20230032A1 (ar) 2023-02-13
ECSP23016038A (es) 2023-04-28
EP4196098A1 (en) 2023-06-21
JP2023538030A (ja) 2023-09-06
US20240041775A1 (en) 2024-02-08
BR112023002654A2 (pt) 2023-04-04
ZA202303273B (en) 2026-02-25
PY2168235A (es) 2022-04-25
US20240350415A1 (en) 2024-10-24
CA3191326A1 (en) 2022-02-17
KR20230067614A (ko) 2023-05-16

Similar Documents

Publication Publication Date Title
KR102164693B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
US20220040113A1 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
JPH07196482A (ja) 有効物質を徐々に遊離する、トラマドール塩含有薬剤
US20260027058A1 (en) New modified release oral contraceptive composition
JP2012126725A (ja) Ｈｒｔ製剤
JPH09500910A (ja) パラセタモール及びドンペリドンのフィルムコーティング錠
EP3162363B1 (en) Composite preparation comprising active ingredient-containing film coating layer
WO2021129735A1 (zh) 一种固体制剂及其制备方法和用途
JP2010536798A (ja) 難溶性薬物の生体利用率を制御するための方法及び組成物
WO2009027786A2 (en) Matrix dosage forms of varenicline
CN115989023A (zh) 多药物递送的系统和方法
JP2023071921A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
US20260021110A1 (en) Methods of oral contraception by controlled release of dienogest and ethynyl estradiol
HK40096856A (en) New modified release oral contraceptive composition
WO2019076966A1 (en) TABLETS COMPRISING TAMSULOSIN AND SOLIFENACIN
BR122025022756A2 (pt) Composição contraceptiva oral de liberação modificada, seu uso, seu processo de obtenção e kit contraceptivo
OA21171A (en) New modified release oral contraceptive composition.
US8426392B2 (en) Method for providing emergency contraception
KR102210982B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
US20250205207A1 (en) Matrix tablets of dexpramipexole and methods of manufacturing and use thereof
US20250186337A1 (en) Chewable oral contraceptive
CN119174735A (zh) 一种含利匹韦林的复方片及制备方法
HK40111725A (en) Method for treating endometriosis and providing effective contraception
HK40108056A (en) Progestogen-only oral contraception
CN108066347A (zh) 包含坦索罗辛和度他雄胺的口腔崩解片药物组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40096856

Country of ref document: HK